Bill Text: PA HB158 | 2009-2010 | Regular Session | Introduced


Bill Title: Requiring the Department of Health to establish bloodborne pathogen standards for emergency services personnel and public employees; establishing the Bloodborne Pathogen Fund; and repealing an act relating to bloodborne pathogen standards.

Spectrum: Moderate Partisan Bill (Democrat 18-5)

Status: (Introduced - Dead) 2009-01-30 - Referred to HEALTH AND HUMAN SERVICES [HB158 Detail]

Download: Pennsylvania-2009-HB158-Introduced.html

  

 

    

PRINTER'S NO.  154

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

HOUSE BILL

 

No.

158

Session of

2009

  

  

INTRODUCED BY SOLOBAY, BELFANTI, BEYER, BRENNAN, CALTAGIRONE, CARROLL, CREIGHTON, FRANKEL, GRUCELA, MAHONEY, MANN, McILVAINE SMITH, MELIO, M. O'BRIEN, READSHAW, SIPTROTH, STABACK AND VULAKOVICH, JANUARY 30, 2009

  

  

REFERRED TO COMMITTEE ON HEALTH AND HUMAN SERVICES, JANUARY 30, 2009  

  

  

  

AN ACT

  

1

Requiring the Department of Health to establish bloodborne

2

pathogen standards for emergency services personnel and

3

public employees; establishing the Bloodborne Pathogen Fund;

4

and repealing an act relating to bloodborne pathogen

5

standards.

6

The General Assembly of the Commonwealth of Pennsylvania

7

hereby enacts as follows:

8

Section 1.  Short title.

9

This act shall be known and may be cited as the Bloodborne

10

Pathogen Standard Act.

11

Section 2.  Definitions.

12

The following words and phrases when used in this act shall

13

have the meanings given to them in this section unless the

14

context clearly indicates otherwise:

15

"Bloodborne pathogen."  A pathogenic microorganism which is

16

present in human blood and can cause disease in humans. The term

17

includes hepatitis B virus (HBV), hepatitis C virus (HCV) and

18

human immunodeficiency virus (HIV).

 


1

"Department."  The Department of Health of the Commonwealth.

2

"Emergency medical services."  The services utilized in

3

responding to the needs of an individual for immediate medical

4

care in order to prevent loss of life or the aggravation of

5

physiological or psychological illness or injury.

6

"Emergency services personnel."  A person, including a

7

trained volunteer or a member of the armed forces of the United

8

States or the National Guard, whose official or assigned

9

responsibilities include performing or directly supporting the

10

performance of emergency medical or rescue services or

11

firefighting.

12

"Employer."  An employer having emergency services personnel

13

or public employees with occupational exposure to blood or other

14

material potentially containing a bloodborne pathogen.

15

"Engineered sharps injury protection."  Any of the following:

16

(1)  A physical attribute built into a needle device used

17

for withdrawing body fluids, accessing a vein or artery or

18

administering medications or other fluids, which effectively

19

reduces the risk of an exposure incident by a mechanism such

20

as barrier creation, blunting, encapsulation, withdrawal,

21

retraction, destruction or other effective mechanisms.

22

(2)  A physical attribute built into any other type of

23

needle device or into a nonneedle sharp which effectively

24

reduces the risk of an exposure incident.

25

"Front-line health care worker."  A nonmanagerial employee

26

responsible for direct patient care with potential occupational

27

exposure to a sharps injury.

28

"Fund."  The Bloodborne Pathogen Fund established in section

29

6.

30

"Needleless system."  A device which does not utilize needles

- 2 -

 


1

for:

2

(1)  the withdrawal of body fluids after initial venous

3

or arterial access is established;

4

(2)  the administration of medication or fluids; or

5

(3)  any other procedure involving the potential for an

6

exposure incident.

7

"Public employee."  An employee of the Commonwealth or a

8

political subdivision employed in a health care facility, home

9

health care organization or other facility providing health

10

care-related services:

11

(1)  whose activities involve contact with a patient or

12

with blood or other body fluid from a patient in a health

13

care or laboratory setting; or

14

(2)  who is responsible for direct patient care with

15

potential occupational exposure to a sharps injury.

16

The term does not include a licensed individual who provides

17

only intraoral care.

18

"Rescue."  The act of extricating persons from entrapment or

19

dangerous situations which pose the imminent threat of death or

20

serious bodily injury.

21

"Sharp."  An object used or encountered in a health care

22

setting which can be reasonably anticipated to penetrate the

23

skin or any other part of the body and to result in an exposure

24

incident. The term includes a needle device, scalpel or lancet;

25

broken glass; or a broken capillary tube.

26

"Sharps injury."  An injury caused by a sharp and resulting

27

in exposure to body fluid. The term includes any cut, abrasion

28

or needlestick.

29

"Sharps injury log."  A written or electronic record of

30

sharps injuries.

- 3 -

 


1

Section 3.  Department.

2

(a)  Adoption of standard.--Within six months of the

3

effective date of this act, the department shall promulgate

4

regulations adopting a bloodborne pathogen standard governing

5

emergency services personnel and public employees. The standard

6

shall be at least as prescriptive as the standard promulgated by

7

the Federal Occupational Safety and Health Review Commission and

8

shall include the following:

9

(1)  A requirement that needleless systems and sharps

10

with engineered sharps injury protection be included as

11

engineering and work practice controls. Engineering controls

12

under this paragraph shall not be required if:

13

(i)  none is available in the marketplace; or

14

(ii)  an evaluation committee, as described in

15

paragraph (3)(iii)(C)(X), determines by means of

16

objective product evaluation criteria that use of such

17

devices will jeopardize patient or employee safety with

18

regard to a specific medical procedure.

19

(2)  A requirement that each emergency service personnel

20

and public employee receive education on the use of an

21

engineering control before a control is introduced into the

22

clinical setting.

23

(3)  A requirement that each employer develop and

24

implement an effective written exposure control plan which

25

includes procedures for all of the following:

26

(i)  Identifying and selecting needleless systems and

27

sharps with engineered sharps injury protection through

28

the evaluation committee described in subparagraph (iii)

29

(C)(X).

30

(ii)  Updating the written exposure control plan when

- 4 -

 


1

necessary, but at least once each year, to reflect

2

progress in implementing needleless systems and sharps

3

with engineered sharps injury protection as determined by

4

the evaluation committee under subparagraph (iii)(C)(X).

5

(iii)  Recording information concerning exposure

6

incidents in a sharps injury log. This subparagraph

7

includes:

8

(A)  Date and time of the exposure incident.

9

(B)  Type and brand of sharp involved in the

10

exposure incident.

11

(C)  Description of the exposure incident. This

12

clause includes:

13

(I)  Job classification of the exposed

14

emergency services personnel or public employee.

15

(II)  Department or work area where the

16

exposure incident occurred.

17

(III)  Procedure which the exposed emergency

18

services personnel or public employee was

19

performing at the time of the incident.

20

(IV)  How the incident occurred.

21

(V)  Body part involved in the exposure

22

incident.

23

(VI)  If the sharp had engineered sharps

24

injury protection, whether the protective

25

mechanism was activated and whether the injury

26

occurred before the protective mechanism was

27

activated, during activation of the mechanism or

28

after activation of the mechanism.

29

(VII)  If the sharp had no engineered sharps

30

injury protection, whether and how such a

- 5 -

 


1

mechanism could have prevented the injury. This

2

subclause requires statement of the basis for the

3

assessment.

4

(VIII)  An assessment of whether any other

5

engineering, administrative or work practice

6

control could have prevented the injury. This

7

subclause requires statement of the basis for the

8

assessment.

9

(IX)  Ensuring that all front-line health

10

care workers are trained on the use of all

11

engineering controls before they are introduced

12

into the clinical setting.

13

(X)  Establishing an evaluation committee, at

14

least half the members of which are public front-

15

line health care workers from a variety of

16

occupational classifications and departments,

17

including nurses, nurse aides, technicians,

18

phlebotomists and physicians, to advise the

19

employer on the implementation of the

20

requirements of the regulations. Members of the

21

committee shall be trained in the proper method

22

of utilizing product evaluation criteria prior to

23

the commencement of product evaluation.

24

(b)  Additional measures.--The department shall consider

25

additional measures to prevent sharps injuries or exposure

26

incidents. This subsection includes training and educational

27

requirements, increased use of vaccinations, strategic placement

28

of sharps containers as close to the work area as practical and

29

increased use of personal protective equipment.

30

(c)  Regulations.--The department may promulgate regulations

- 6 -

 


1

to implement this act.

2

(d)  Transitional period for certain drugs and biologics.--

3

The use of a drug or biologic which is prepackaged with an

4

administration system or used in a prefilled syringe and is

5

approved for commercial distribution or investigational use by

6

the Federal Food and Drug Administration is exempt for a

7

standard adopted under subsection (a) or additional measures

8

adopted under subsection (b) for a period of three years from

9

the effective date of this act.

10

(e)  Compilation and maintenance of list.--The department

11

shall compile and maintain a list of needleless systems and

12

sharps with engineered sharps injury protection. The list shall

13

be available to assist employers in complying with the

14

requirements of the regulations promulgated under this section.

15

The list may be developed from existing sources of information,

16

including the Federal Food and Drug Administration, the Federal

17

Centers for Disease Control, the National Institute of

18

Occupational Safety and Health and the United States Department

19

of Veterans Affairs.

20

Section 4.  Employers.

21

(a)  Complaints.--Each employer shall develop and implement

22

compliance monitoring procedures and a complaint process.

23

(b)  Review.--Each employer shall provide its emergency

24

service personnel and public employees an opportunity to

25

evaluate engineered sharps injury prevention devices and

26

needleless systems in an accident and illness prevention

27

program.

28

Section 5.  Applicability to contractors.

29

Nothing in this act shall prohibit an employer from applying

30

the principles of this act to a contractor.

- 7 -

 


1

Section 6.  Fund.

2

(a)  Establishment.--The Bloodborne Pathogen Fund is

3

established in the State Treasury.

4

(b)  Purposes.--The department shall utilize the fund to do

5

all of the following:

6

(1)  Implement this act.

7

(2)  In needleless systems and sharps with engineered

8

sharps injury protection, provide for research, development

9

and product evaluation.

10

(c)  Source.--The source of the fund is appropriations.

11

(d)  Continuous appropriation.--The money in the fund is

12

continuously appropriated to the fund. This appropriation shall

13

not lapse at the end of any fiscal year.

14

Section 7.  Repeal.

15

(a)  Intent.--The General Assembly declares that the repeal

16

under subsection (b) is necessary to effectuate the provisions

17

of this act.

18

(b)  Provision.--The act of December 13, 2001 (P.L.873, No.

19

96), known as the Bloodborne Pathogen Standard Act, is repealed.

20

Section 8.  Effective date.

21

This act shall take effect in 120 days.

- 8 -

 


feedback